rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    TELA
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      TELA Bio Inc (TELA) (Q3 2026) Earnings Call Highlights: Cost Cuts, Leora Clearance and a Reset ...
      Nov 11Yahoo FinanceTELA
      TELA Bio, Inc. Q3 2026 Earnings Call Summary
      Nov 11Yahoo FinanceTELA
      Tela Bio earnings beat by $0.03, revenue fell short of estimates
      Nov 10Investing.comTELA
      TELA Bio Q3 2026 Earnings Call Transcript
      Nov 10BenzingaTELA
      TELA Bio, Inc. (TELA) Reports Q3 Loss, Beats Revenue Estimates
      Nov 10Yahoo FinanceTELA
      TELA Bio Reports Third Quarter 2026 Financial Results
      Nov 10Yahoo FinanceTELA
      Earnings To Watch: TELA Bio Inc (TELA) Q3 2026 -- GF Value Sees 74% Upside
      Nov 9Yahoo FinanceTELA
      TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

      MALVERN, Pa., Nov. 06, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of restricted stock units covering 108,550 shares of its common stock to four newly-hired employees, with a grant date of November 4, 2026 (the "Grant Date"). The restricted stock

      Nov 6Yahoo FinanceTELA
      TELA Bio to Announce Third Quarter 2026 Financial Results

      MALVERN, Pa., Oct. 27, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will report third quarter 2026 financial results on Tuesday, November 10, 2026. TELA Bio’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update. Third Quarter Earnings Conf

      Oct 27Yahoo FinanceTELA
      TELA Bio (TELA) Stock Sees Fair Value Cut As Analysts Weigh New Leadership Risks
      Oct 19Yahoo FinanceTELA
      TELA Bio Regains Nasdaq Compliance, Securing Listing Status

      Detailed price information for Tela Bio Inc (TELA-Q) from The Globe and Mail including charting and trades.

      Oct 7The Globe and MailTELA
      TELA Bio receives FDA clearance for resorbable mesh device
      Oct 6Investing.comTELA
      TELA Bio gains short-term relief on loan covenants

      Detailed price information for Tela Bio Inc (TELA-Q) from The Globe and Mail including charting and trades.

      Sep 30The Globe and MailTELA
      Tela Bio director Capper acquires $78,442 in company stock
      Sep 17Investing.comTELA
      Tela Bio CEO Heather Getz buys $8,311 in company stock
      Sep 3Investing.comTELA
      Wall Street Analysts Are Bullish on Top Healthcare Picks

      Detailed price information for Jazz Pharma Plc (JAZZ-Q) from The Globe and Mail including charting and trades.

      Sep 1The Globe and MailTELA
      TELA Bio cuts 20% of workforce to reduce costs by $17M annually
      Aug 31Investing.comTELA
      TELA Bio Announces COO / CFO Transition and Strategic Cost Reduction Initiative

      Company to reduce annual operating expenses by $17.0 million or 18% as part of broader efficiency programMALVERN, Pa., Aug. 31, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio” or the “Company”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that Roberto Cuca, Chief Operating Officer and Chief Financial Officer, will step down from the role effective today. “On behalf of the Board and management team, I woul

      Aug 31Yahoo FinanceTELA
      Tela Bio CEO Heather Getz buys $8,311 in company stock
      Aug 26Investing.comTELA

      This is the newest page. Registered accounts read further back.